Interleukin -1β -induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expressionJAGER, Jennifer; GREMEAUX, Thierry; CORMONT, Mireille et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 1, pp 241-251, issn 0013-7227, 11 p.Article

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in Patients with type 1 diabetesRASKIN, Philip; KLAFF, Leslie; BERGENSTAL, Richard et al.Diabetes care. 2000, Vol 23, Num 11, pp 1666-1671, issn 0149-5992Article

Analogues de l'insuline = Insulin analogsMOSNIER-PUDAR, Helen.MTE. Médecine thérapeutique endocrinologie. 2000, Vol 2, Num 6, pp 540-545, issn 1295-9359Article

Les nouvelles insulines : intérêts et inconvénients = New insulins : interests and convenientsSOLA, A; LARGER, E; M'BEMBA, J et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 6, pp 454-460, issn 1624-0693, 7 p.Article

A critical appraisal of the role of insulin analogues in the management of diabetes mellitusOIKNINE, Ralph; BERNBAUM, Marla; MOORADIAN, Arshag D et al.Drugs (Basel). 2005, Vol 65, Num 3, pp 325-340, issn 0012-6667, 16 p.Article

Etiology of insulin resistancePETERSEN, Kitt Falk; SHULMAN, Gerald I.The American journal of medicine. 2006, Vol 119, Num 5A, pp 10S-16S, issn 0002-9343, SUPConference Paper

Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intoleranceHENGJIANG DONG; MADDUX, Betty A; ALTOMONTE, Jennifer et al.Diabetes (New York, NY). 2005, Vol 54, Num 2, pp 367-372, issn 0012-1797, 6 p.Article

Development of a Process to Manufacture PEGylated Orally Bioavailable InsulinHAZRA, Partha; ADHIKARY, Laxmi; DAVE, Nitesh et al.Biotechnology progress. 2010, Vol 26, Num 6, pp 1695-1704, issn 8756-7938, 10 p.Article

The dynamic insulin sensitivity and secretion test-a novel measure of insulin sensitivityMCAULEY, Kirsten A; BERKELEY, Juliet E; DOCHERTY, Paul D et al.Metabolism, clinical and experimental. 2011, Vol 60, Num 12, pp 1748-1756, issn 0026-0495, 9 p.Article

A novel insulin analog with unique properties: Lys^B3, Glu^B29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1RAKATZI, Irini; RAMRATH, Stefanie; LEDWIG, Daniela et al.Diabetes (New York, NY). 2003, Vol 52, Num 9, pp 2227-2238, issn 0012-1797, 12 p.Article

Insulinothérapie fonctionnelleAMOUYAL, Chloé.La Revue du praticien. Médecine générale. 2013, Num 909, pp 720-721, issn 0989-2737, 2 p.Article

Insulinothérapie après 85 ansBOURDEL-MARCHASSON, Isabelle; MORAS, Jean-Baptiste.La Revue du praticien. Médecine générale. 2013, Num 911, pp 801-802, issn 0989-2737, 2 p.Article

Epilepsia partialis continua stopped by insulinKUMAR, S.Journal of the Royal Society of Medicine. 2004, Vol 97, Num 7, pp 332-333, issn 0141-0768, 2 p.Article

Les pompes à insuline portables (ou sous-cutanées)CERF-BARON, Isabelle.Diabétologie et facteurs de risque. 2001, Vol 7, Num 62, pp 254-257, issn 1267-6527Article

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetesHERMANSEN, Kjeld; COLOMBO, Michele; STORGAARD, Heidi et al.Diabetes care. 2002, Vol 25, Num 5, pp 883-888, issn 0149-5992Article

Recent advances in treatment of youth with Type 1 diabetes : better care through technologyTAMBORLANE, W. V; BONFIG, W; BOLAND, E et al.Diabetic medicine. 2001, Vol 18, Num 11, pp 864-870, issn 0742-3071Article

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metforminKILO, Charles; MEZITIS, Nicholas; JAIN, Rajeev et al.Journal of diabetes and its complications. 2003, Vol 17, Num 6, pp 307-313, issn 1056-8727, 7 p.Article

Premixed insulin analogues for the treatment of diabetes mellitusGARBER, Alan J.Drugs (Basel). 2006, Vol 66, Num 1, pp 31-49, issn 0012-6667, 19 p.Article

Intensifying Insulin Therapy in Type 2 Diabetes Mellitus: Dosing Options for Insulin Analogue PremixesTIBALDI, Joseph M.Clinical therapeutics. 2011, Vol 33, Num 11, pp 1630-1642, issn 0149-2918, 13 p.Article

Preproghrelin expression is a key target for insulin action on adipogenesisGURRIARAN-RODRIGUEZ, Uxía; AL-MASSADI, Omar; CASANUEVA, Felipe F et al.Journal of endocrinology. 2011, Vol 210, Num 2, issn 0022-0795, R1-R7Article

Osmolyte Controlled Fibrillation Kinetics of Insulin: New Insight into Fibrillation Using the Preferential Exclusion PrincipleNAYAK, Arpan; LEE, Chuang-Chung; MCRAE, Gregory J et al.Biotechnology progress. 2009, Vol 25, Num 5, pp 1508-1514, issn 8756-7938, 7 p.Article

THE STRUCTURE AND FUNCTION OF INSULIN : DECODING THE TR TRANSITIONWEISS, Michael A.Vitamins and hormones. 2009, Vol 80, pp 33-49, issn 0083-6729, 17 p.Article

Education du patient diabétique sous insulineSociologie du travail. 1995, Num 37, issn 0038-0296, 20Article

Insulin clearance and diabetesMCKEIGUE, P. M; UUISTUPA, M; LAITINEN, J et al.Lancet (British edition). 1991, Vol 338, Num 8777, pp 1270-1271, issn 0140-6736Article

Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glarginePING WU; CHENG JI; MINGLI WANG et al.Annales d'endocrinologie. 2013, Vol 74, Num 1, pp 56-58, issn 0003-4266, 3 p.Article